VHAM
IDXX icon

Van Hulzen Asset Management’s Idexx Laboratories IDXX Stock Holding History

Van Hulzen Asset Management’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-49
Closed -$20.3K – 659
2024
Q4 		$20.3K Buy
+49
New +$21.5K ﹤0.01% 676

Other funds holding IDXX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fundsmith LLP
Fundsmith LLP London, United Kingdom $12.8B AUM 6.9% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $33.1B AUM 11.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Principal Financial Group
Principal Financial Group Des Moines, Iowa $187B AUM 18.48% 1-Year Est. Return

Van Hulzen Asset Management's IDXX Position: Q1 2025 in Review

Van Hulzen Asset Management sold out of Idexx Laboratories (IDXX) in Q1 2025, closing a stake of 49 shares — an estimated $20.3K sold.

Van Hulzen Asset Management first reported a position in IDXX in Q4 2024 and held it in 1 quarter. The position peaked at $20.3K in Q4 2024. 1,142 funds tracked by Wall St. Rank hold IDXX as of Q1 2025.

  • Van Hulzen Asset Management reported no remaining Idexx Laboratories position as of Q1 2025 after selling out during the quarter.
  • Van Hulzen Asset Management sold 49 Idexx Laboratories shares in Q1 2025, an estimated $20.3K.
  • Van Hulzen Asset Management first reported a position in Idexx Laboratories in Q4 2024 and held it in 1 quarter.
  • Van Hulzen Asset Management's Idexx Laboratories position peaked at $20.3K in Q4 2024.
  • 1,142 funds tracked by Wall St. Rank held Idexx Laboratories as of Q1 2025.

Based on Van Hulzen Asset Management's 13F filing for Q1 2025, filed 14 May 2025.